GFAP and stroke disorder: A two-way ANOVA assessing GFAP+ve staining in the CC of vehicle- and compound A-treated animals revealed significant overall effects of stroke (F1,33 = 19.90, p < 0.0001) and compound A treatment (F1,33 = 9.04, p = 0.0015), as well as a significant interaction between these factors (F1,33 = 6.317, p = 0.0170).